OakChart

DarioHealth Corp

DRIOHealthcare·Health Information Services·USA·Nano·NASD·Nov 11 • 2:05 PM ET

2.27-0.12 (-5.02%)
2026-11-11 20:12 CET
Market cap
23.42 USD m
Revenue, TTM
21.00 USD m
Net income, TTM
-41.86 USD m
Free cash flow, TTM
-25.48 USD m
EPS diluted, TTM
-7.49
P/E
-
Compare

Price

DRIO against its 20, 50 and 200-day averages
2050200beatearnings
2.505.007.5010.00133K266KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DRIOclose 2.2720-day 3.3450-day 5.25200-day 7.372.2752w low

84.6% under the 52-week high of 14.77 on 20 Nov 2025. 52-week low 1.70 on 10 Nov 2026. Last 15 sessions, 138.1% high to low

Profile

DRIO
52-week range, 4% of the way up
1.7014.77

DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.

Employees165
IPOApr 09, 2013
Beta1.20
ATR, 14d0.51
Rel volume1.56
Short float1.56%
Insider own25.07%
Inst own9.08%

Snapshot

6 groups

Valuation

Index-
Market Cap22.24M
Enterprise Value40.40M
Income-41.86M
Sales21.00M
Book/sh7.50
Cash/sh1.45
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees165
IPOApr 09, 2013

Ratios

P/E-
Forward P/E-
PEG-
P/S1.06
P/B0.30
P/C1.56
P/FCF-
EV/EBITDA-
EV/Sales1.92
Quick Ratio1.92
Current Ratio2.31
Debt/Eq0.59
LT Debt/Eq0.58
Option/ShortNo / Yes

Earnings

EPS (ttm)-7.49
EPS next Y-2.52
EPS next Q-0.95
EPS this Y60.70%
EPS next Y36.63%
EPS next 5Y45.15%
EPS past 3/5Y41.57% 38.06%
Sales past 3/5Y-6.84% 24.17%
EPS Y/Y TTM62.36%
Sales Y/Y TTM-22.65%
EPS Q/Q78.49%
Sales Q/Q-3.58%
EarningsNov 12 BMO
EPS/Sales Surpr.30.04% -12.56%

Ownership

Insider Own25.07%
Insider Trans0.59%
Inst Own9.08%
Inst Trans2.25%
ROA-32.34%
ROE-55.65%
ROIC-38.12%
Gross Margin58.15%
Oper. Margin-151.60%
Profit Margin-199.33%
SMA20-32.04%
SMA50-56.79%
SMA200-69.20%
Trades-

Technical

Shs Outstand9.80M
Shs Float7.34M
Short Float1.56%
Short Ratio2.90
Short Interest0.11M
52W High14.77 -84.63%
52W Low1.70 33.90%
Volatility23.11% 16.71%
ATR (14)0.51
RSI (14)24.55
Beta1.20
Rel Volume1.56
Avg Volume39.50K
Volume45,241

Performance

Perf Week-23.57%
Perf Month-59.03%
Perf Quarter-69.03%
Perf Half Y-71.98%
Perf YTD-80.05%
Perf Year-81.32%
Perf 3Y-89.39%
Perf 5Y-99.35%
Perf 10Y-99.82%
Recom1.40
Target Price9.20
Prev Close2.39
Price2.27
Change %-5.02%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
Oct 27, 2026InitiatedBBTIG ResearchBuy$6+164.3%
Aug 19, 2026InitiatedAAlliance Global PartnersBuy$12+428.6%
Jan 29, 2025DowngradeTTD CowenBuy → Hold$2 → $1-55.9%
May 13, 2022UpgradeAAlliance Global PartnersNeutral → Buy$8.75+285.5%
Apr 22, 2021InitiatedCCowenOutperform$31+1,265.6%
Mar 23, 2021InitiatedSStifelBuy$30+1,221.6%
Feb 25, 2021InitiatedCCantor FitzgeraldOverweight$35+1,441.9%
Feb 01, 2021DowngradeAAlliance Global PartnersBuy → Neutral$15.60 → $22.25+880.2%
Aug 17, 2020InitiatedAAegis CapitalBuy$25+1,001.3%
Aug 29, 2017InitiatedAAegis CapitalBuy$3.50+54.2%

Peers

Mkt cap
TickerCompanyMkt cap
OMDAOmada Health Inc964.02M
HNGEHinge Health Inc9.58B
TDOCTeladoc Health Inc1.66B
LFMDLifeMD Inc85.28M
AMWLAmerican Well Corp209.23M
BEATHeartBeam Inc23.19M
HCATHealth Catalyst Inc108.81M
DOCSDoximity Inc5.95B
PHRPhreesia Inc793.58M
HIMSHims & Hers Health Inc4.80B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Matheis DennisDirectorJul 23 '26Buy6.9314,430100,00043,026Jul 28 05:27 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.38B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M

News

latest 14 of 200
  • DarioHealth's First Second-Half Quarter Tests Whether Signed Contracts Finally Show Up As Revenue (Earnings Whispers) -12.84%
  • Dario Names Veteran Healthcare Executive John R. Palumbo Chairman of the Board as Company Positions Itself to Lead the Convergence of Consumer and Payer-Funded Care (PR Newswire)
  • DarioHealth to Report Third Quarter 2026 Results on Thursday, November 12, 2026 (PR Newswire)
  • Dario Expands Contract with a Leading Regional Grocery Retailer, Adding Women's Digital Health and Clinical Care Program (PR Newswire) -9.81%
  • DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs (PR Newswire)
  • Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives (PR Newswire)
  • DarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ... (GuruFocus.com)
  • DarioHealth Corp (DRIO) Q2 2026 Earnings Report Preview: What To Look For (GuruFocus.com)
  • DarioHealth Reports Second Quarter 2026 Financial Results (PR Newswire)
  • CoreWeaves Forecast Is Key to Stopping Another Earnings Selloff (Bloomberg)
  • Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand (PR Newswire)
  • DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026 (PR Newswire)
  • Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience (PR Newswire)
  • Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire) +12.86%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.950--5.213
2026Q22026-08-11-0.850-1.215-0.8505.185.922
2026Q12026-05-13-1.250-1.480-1.2535.585.462
2025Q42026-03-19-2.267-3.243-2.3325.205.054
2025Q32025-11-13-2.960-4.900-3.0525.015.674
2025Q22025-08-12-3.600-4.667-3.9425.376.913
2025Q12025-05-14-2.800-2.000-5.9396.757.473
2024Q42025-03-10-1.600-6.666-5.1017.607.393
2024Q32024-11-07-5.000-4.334-4.9077.427.403
2024Q22024-08-08-1.600-8.900-1.6926.267.922
2024Q12024-05-15-4.000-5.900-4.0175.806.762
2023Q42024-03-28-8.200-7.800-8.8273.603.783
2023Q32023-11-02-9.800-10.400-9.8533.525.425
2023Q22023-08-10-11.600-10.280-11.5936.156.505
2023Q12023-05-11-9.000-9.960-9.0167.076.705
2022Q42023-03-09-8.400-12.200-10.5906.816.715

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-160-78.500-184.387.567.90
2020FY-111.02-102.5-111.027.587.60
2021FY-92.530-94.372-94.94620.5120.61
2022FY-50.800-58.680-50.73627.6627.59
2023FY-38.600-30.800-38.67220.3520.51
2024FY-12.200-22.467-12.27127.0426.81
2025FY-10.120-11.492-10.12022.3622.44
2026FY--3.977--21.58
2027FY--2.520--27.36
2028FY--1.670--35.06
2029FY--1.590--39.06
2030FY--1.170--49.50

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-264005.215.115.34
2026Q3S2026-10-253005.245.195.34
2026Q3S2026-08-173025.245.195.34
2026Q3S2026-08-112025.195.195.20
2026Q3S2026-07-272006.646.446.83
2026Q3S2026-06-022016.646.446.83
2026Q3S2026-05-132116.646.446.83
2026Q3S2026-04-232106.706.407.00
2026Q3S2026-04-093106.876.407.20
2026Q3S2026-04-063106.876.427.20
2026Q3S2026-03-193116.876.427.20
2026Q3S2026-01-272016.425.647.20
2026Q3S2026-01-212026.425.647.20
2026Q3S2025-11-172027.975.6410.30

Estimate history

EPS, annual-664.628-312.58-184.376-111.022-94.946-50.736-38.672-12.271-10.121-7.4855
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.692-4.907-5.101-5.939-3.942-3.052-2.332-1.253-0.848
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual5.177.3947.5597.57620.51327.65620.35227.0422.35921
Period201720182019202020212022202320242025TTM
Sales, quarterly6.2557.4237.6046.7525.3695.0075.2315.5845.177
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0350.0920.1120.4060.8291.2861.361.9196.9067.342
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.5011.5661.9192.1352.2746.7686.9067.2997.342
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue21.0022.3627.0420.3527.6620.517.587.567.39
Cost of Goods Sold Incl. D&A8.799.6913.7714.3718.0016.555.064.965.63
Gross Profit12.2112.6613.275.989.653.962.512.601.76
Selling, General and Administrative Excl. Other44.0549.3270.2862.0566.9679.5832.4220.3019.45
Research and Development10.4513.7924.1820.2519.6517.224.433.693.68
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-31.83-36.66-57.02-56.06-57.31-75.61-29.90-17.70-17.69
Interest Expense4.843.360.100.652.680.080.050.030.02
Unusual Expense-1.042.26-11.404.322.950.880.000.00-0.00
Net Income Before Taxes-35.20-41.61-44.60-59.36-62.19-76.73-29.45-17.74-17.80
Income Taxes0.470.10-1.850.060.000.030.000.000.00
Consolidated Net Income-33.14-20.29-30.09-54.86-59.96-76.76-29.45-17.74-17.80
Net Income From Continuing Operations-33.14-20.29-30.09-54.86-59.96-76.76-29.45-17.74-17.80
Net Income-41.86-40.31-30.09-54.86-59.96-78.77-33.10-20.89-18.30
EPS (Recurring)-4.56-9.72-15.53-36.54-48.99-94.20-111.02-184.38-312.59
EPS (Basic, Before Extraordinaries)-7.49-10.12-12.27-38.67-50.74-94.95-111.02-184.38-312.58
EPS (Diluted)-7.49-10.12-12.27-38.67-50.74-94.95-111.02-184.38-312.58
EBITDA-29.06-33.10-48.68-50.84-53.51-72.09-29.45-17.15-17.48
Non-Operating Income (Expense)0.430.671.111.660.75-0.150.51-0.00-0.10
Other After Tax Adjustments2.5321.4312.664.572.240.000.000.000.00
Stock Option Compensation Expense5.587.4012.4815.5613.4124.9711.102.323.76
Price To Sales Ratio2.942.031.432.403.6610.4911.251.972.46
Gross Margin58.1556.6449.0629.4034.9119.3233.1734.3623.87
Operating Margin-151.60-163.94-210.85-275.46-207.21-368.62-394.71-234.22-239.22
Net Margin-199.33-180.28-111.28-269.56-216.80-383.98-436.95-276.37-247.44
Shares Outstanding7.346.911.921.361.290.830.410.110.09
Market Capitalization23.4223.4230.1846.8199.69214.96116.0314.6728.41

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue5.185.585.235.015.376.757.607.42
Cost of Goods Sold Incl. D&A1.992.382.431.992.402.873.403.55
Gross Profit3.193.202.803.022.963.884.203.88
Selling, General and Administrative Excl. Other9.6710.5111.3712.5012.1613.2915.8515.91
Research and Development2.102.382.633.333.724.115.285.45
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.48-7.31-8.56-9.48-9.20-9.41-11.65-12.03
Interest Expense1.141.171.341.190.030.030.020.03
Unusual Expense-0.01-0.18-0.78-0.083.790.09-2.090.50
Net Income Before Taxes-7.60-8.19-8.95-10.47-12.99-9.21-9.48-12.34
Income Taxes0.330.060.080.000.000.020.15-0.01
Consolidated Net Income-7.92-8.25-14.89-2.08-7.42-9.23-9.79-9.92
Net Income From Continuing Operations-7.92-8.25-14.89-2.08-7.42-9.23-9.79-9.92
Net Income-7.92-8.25-16.11-9.58-9.78-14.07-9.79-9.92
EPS (Recurring)-0.85-1.27-2.41-3.07-2.87-5.91-5.86-4.74
EPS (Basic, Before Extraordinaries)-0.85-1.25-2.33-3.05-3.94-5.94-5.10-4.91
EPS (Diluted)-0.85-1.25-2.33-3.05-3.94-5.94-5.10-4.91
EBITDA-5.84-6.67-7.61-8.94-8.40-8.15-8.61-9.90
Non-Operating Income (Expense)0.020.110.180.130.030.330.100.21
Other After Tax Adjustments0.000.00-5.858.395.570.00-0.162.41
Stock Option Compensation Expense0.501.141.612.332.041.852.052.20
Price To Sales Ratio2.942.493.512.201.221.031.121.96
Gross Margin61.6657.3153.6060.2255.2157.4955.2652.23
Operating Margin-125.15-130.89-163.68-189.41-171.35-139.35-153.24-162.06
Net Margin-153.06-147.73-307.90-191.28-182.22-208.32-128.76-133.59
Shares Outstanding7.347.306.916.772.272.141.921.57
Market Capitalization23.4258.5577.0241.6430.4726.1430.1835.08

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments26.2528.6437.0949.5236.0028.7820.5911.183.98
Short Term Receivables2.675.093.406.661.791.700.710.230.43
Inventories4.324.755.067.966.232.291.411.381.18
Other Current Assets1.581.791.540.911.591.350.200.450.45
Total Current Assets34.8140.2747.0965.0445.6034.1322.9113.246.05
Net Property, Plant & Equipment1.271.771.871.990.991.071.410.730.87
Total Investments and Advances0.080.080.010.010.020.020.020.040.04
Intangible Assets73.3676.1947.0451.5654.10--0.000.00
Other Assets0.560.570.380.590.060.180.220.070.00
Total Assets110.08118.8896.39119.19100.7735.4124.5714.096.96
Short Term Debt Incl. Current Port. of LT Debt0.435.964.079.120.270.310.320.000.00
Accounts Payable2.933.041.132.325.112.481.662.571.85
Other Current Liabilities5.967.637.307.919.004.243.252.591.16
Total Current Liabilities9.3216.6412.4919.3514.387.035.225.163.02
Long Term Debt31.3224.2425.4818.930.020.220.460.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.515.990.280.910.820.000.000.000.00
Total Liabilities42.1546.8738.2439.1915.227.265.675.163.02
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity67.9272.0258.1480.0085.5528.1518.898.933.94
Total Shareholders Equity67.9272.0258.1480.0085.5528.1518.898.933.94
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity67.9272.0258.1480.0085.5528.1518.898.933.94
Total Liabilities & Stockholders Equity110.08118.8896.39119.19100.7735.4124.5714.096.96
Book Value Per Share9.8437.5242.7762.20103.2469.34169.0297.52112.01
Tangible Book Value Per Share-0.79-2.178.1622.1137.9569.34169.0297.52112.01
Full-Time Employees165202276241200127726948
Price to Book Ratio0.320.420.691.122.514.120.783.182.68
Return on Assets-17.72-27.95-50.90-54.52-112.74-98.19-91.76-169.18-290.76
Return on Equity-29.00-46.23-79.43-72.43-135.02-125.18-127.51-276.74-
Return on Invested Capital-20.44-31.26-65.61-60.60-89.71-103.78-91.66-199.47-399.47
Quick Ratio3.272.143.362.952.744.534.122.301.61
Current Ratio3.732.423.773.363.174.854.392.562.01

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-35.67-41.71-42.75-59.43-62.19-76.76-29.45-17.74-17.80
Depreciation2.783.568.335.223.803.530.460.550.21
Other Funds (Non Cash)7.5210.0115.2219.4616.9826.1111.102.263.76
Funds from Operations-25.38-28.15-19.20-34.74-41.42-47.12-17.89-14.93-13.84
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.032.21-19.364.36-6.42-3.290.15-0.802.37
Cash from Operating Activities-25.34-25.94-38.56-30.38-47.84-50.41-17.74-15.72-11.47
Capital Expenditures-0.14-0.14-0.14-0.58-0.57-0.26-0.12-0.10-0.07
Net Assets From Acquisitions0.000.00-8.800.000.00-7.470.000.00-
Sale of Fixed Assets and Businesses0.010.000.000.000.00-0.000.00-
Purchase or Sale of Investments-7.25-4.200.000.040.000.00-0.00-0.010.08
Purchase of Investments-13.45-4.200.00-5.000.000.00-0.00-0.01-0.00
Sale Or Maturity of Investments6.200.000.005.030.000.000.000.000.08
Other Uses0.000.000.000.000.00-0.40-1.500.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-7.38-4.34-8.93-0.55-0.57-8.13-1.62-0.110.01
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock17.3724.1338.5316.4838.1565.7727.5525.2518.74
Repurchase of Common Pref Stock0.000.000.000.00-0.130.000.000.000.00
Sale of Common Pref Stock17.3724.1338.5316.4838.2965.7727.5525.2518.74
Proceedsfrom Stock Options6.756.7538.5314.8738.2964.880.0025.250.00
Issuance or Reduction of Debt, Net0.000.180.001.7723.790.000.000.000.00
Change in Long Term Debt0.000.180.001.7723.790.000.000.000.00
Issuance of Long Term Debt0.0031.700.0029.6023.790.000.000.000.00
Reduction of Long Term Debt0.00-31.520.00-27.830.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities17.3724.3138.5318.2561.9465.7727.5525.2518.74
Exchange Rate Effect0.030.01-------
Net Change in Cash-15.32-5.96-8.96-12.6713.527.228.199.417.28
Free Cash Flow-25.48-26.08-38.70-30.96-48.29-50.67-17.85-15.82-11.54
Preferred Dividends (Cash Flow)--0.000.000.00----
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments14.2520.2626.2532.1322.1728.05
Short Term Receivables1.552.222.672.382.563.21
Inventories3.724.174.324.874.614.62
Other Current Assets2.601.811.582.812.832.69
Total Current Assets22.1328.4734.8142.1932.1738.56
Net Property, Plant & Equipment1.531.121.271.321.471.60
Total Investments and Advances0.120.080.080.080.080.08
Intangible Assets72.4372.8973.3673.8374.3175.03
Other Assets0.390.720.560.310.300.33
Total Assets96.59103.28110.08117.73108.33115.60
Short Term Debt Incl. Current Port. of LT Debt0.570.380.430.440.5110.79
Accounts Payable3.173.472.933.473.382.75
Other Current Liabilities5.835.515.965.375.875.62
Total Current Liabilities9.589.369.329.289.7519.16
Long Term Debt31.8431.4431.3231.2031.1119.55
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.080.111.512.323.473.19
Total Liabilities41.5040.9042.1542.7944.3441.90
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity55.0962.3867.9274.9363.9973.70
Total Shareholders Equity55.0962.3867.9274.9363.9973.70
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity55.0962.3867.9274.9363.9973.70
Total Liabilities & Stockholders Equity96.59103.28110.08117.73108.33115.60
Book Value Per Share7.508.559.8411.0728.1434.51
Tangible Book Value Per Share-2.36-1.44-0.790.16-4.54-0.62
Full-Time Employees--165---
Price to Book Ratio0.320.821.030.620.480.35
Return on Assets-32.34-29.81-29.36-25.05-31.55-25.58
Return on Equity-55.65-47.96-48.03-42.73-55.06-42.58
Return on Invested Capital-9.12-8.79-15.00-1.96-7.80-9.89
Quick Ratio1.922.603.274.022.831.77
Current Ratio2.313.043.734.553.302.01

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-7.92-8.25-9.03-10.47-12.99-9.23
Depreciation0.640.630.950.550.801.26
Other Funds (Non Cash)0.691.402.363.062.132.45
Funds from Operations-6.59-6.21-5.71-6.86-10.06-5.52
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.510.19-0.17-0.494.03-1.15
Cash from Operating Activities-6.08-6.03-5.89-7.35-6.03-6.67
Capital Expenditures-0.04-0.03-0.03-0.04-0.04-0.03
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.010.000.000.000.00
Purchase or Sale of Investments-2.25-0.80-4.200.000.000.00
Purchase of Investments-4.25-5.00-4.200.000.000.00
Sale Or Maturity of Investments2.004.200.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-2.29-0.83-4.23-0.04-0.04-0.03
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.00----
Change in Capital Stock0.000.00-0.0217.39-0.066.82
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.00-0.0217.39-0.066.82
Proceedsfrom Stock Options0.000.006.750.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.180.00
Change in Long Term Debt0.000.000.000.000.180.00
Issuance of Long Term Debt0.000.000.000.0031.700.00
Reduction of Long Term Debt0.000.000.000.00-31.520.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.000.00-0.0217.390.126.82
Exchange Rate Effect0.030.030.03-0.050.05-0.02
Net Change in Cash-8.34-6.83-10.109.95-5.900.09
Free Cash Flow-6.12-6.06-5.91-7.39-6.08-6.70

Revenue breakdown

Hardware and Consumable Products2024: 6.84M 2025: 7.43M
Service2024: 20.20M 2025: 14.93M
United States2024: 27.04M 2025: 22.36M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.56%0.1M7.3M36.80K
2026-10-151.11%0.1M7.3M24.65K
2026-09-301.06%0.1M7.7M24.33K
2026-09-150.94%0.1M8.3M23.62K
2026-08-310.91%0.1M8.3M19.95K
2026-08-141.00%0.1M8.3M16.71K
2026-07-311.11%0.1M7.8M12.65K
2026-07-151.30%0.1M5.8M10.64K
2026-06-301.32%0.1M5.8M11.72K
2026-06-151.37%0.1M5.8M12.10K
2026-05-291.21%0.1M5.8M12.45K
2026-05-151.25%0.1M5.8M12.89K
2026-04-301.15%0.1M5.8M16.61K
2026-04-151.19%0.1M5.8M15.70K
2026-03-311.16%0.1M5.7M14.02K
2026-03-130.79%0.0M5.7M17.40K
2026-02-270.96%0.1M5.3M19.89K
2026-02-131.27%0.1M5.3M24.86K
2026-01-301.22%0.1M5.3M23.76K
2026-01-151.48%0.1M5.3M28.19K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-068-KCurrent report2026-11-03SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-284Statement of changes in beneficial ownership of securities2025-09-18SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-284Statement of changes in beneficial ownership of securities2024-08-12SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-284Statement of changes in beneficial ownership of securities2024-08-12SEC
2026-09-283Initial statement of beneficial ownership of securities2026-09-24SEC
2026-09-048-KCurrent report2026-09-02SEC
2026-08-218-KCurrent report2026-08-20SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-284Statement of changes in beneficial ownership of securities2024-08-12SEC
2026-07-228-KCurrent report2026-07-22SEC
2026-07-22424B5SEC
2026-07-108-KCurrent report2026-07-10SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-07SDSpecialized Disclosure ReportSEC
2026-04-133Initial statement of beneficial ownership of securities2026-04-10SEC
2026-04-138-KCurrent report2026-04-10SEC
2026-03-308-KCurrent report2026-03-30SEC
2026-03-30424B5SEC
2026-03-27EFFECTEffectiveness filing by commission orderSEC
2026-03-25CORRESPSEC
2026-03-25UPLOADUpload SubmissionSEC
2026-03-19S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-03-19S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-03-1910-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-13SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-07100.00K100
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Nantahala Capital Management, LLC16.70%
VANGUARD CAPITAL MANAGEMENT LLC0.90%
GEODE CAPITAL MANAGEMENT, LLC0.69%
BlackRock, Inc.0.52%
VANGUARD FIDUCIARY TRUST CO0.51%
CITADEL ADVISORS LLC0.33%
COMMONWEALTH EQUITY SERVICES, LLC0.24%
NORTHERN TRUST CORP0.18%
Vanguard Global Advisers, LLC0.05%
MORGAN STANLEY0.04%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.90%
Fidelity Extended Market Index Fund0.33%
iShares Micro-Cap ETF0.25%
Fidelity Total Market Index Fund0.10%
Fidelity Series Total Market Index Fund0.09%
1290 VT Micro Cap Portfolio0.02%
U.S. CORE EQUITY 1 PORTFOLIO0.01%
U.S. Social Core Equity 2 Portfolio0.01%
U.S. CORE EQUITY 2 PORTFOLIO0.01%
Dimensional US Sustainability Core 1 ETF0.01%

OakChart. DRIO. Cached 15 minutes.